High dose chemotherapy in ovarian cancer
- 1 July 2001
- journal article
- review article
- Published by BMJ in International Journal of Gynecologic Cancer
- Vol. 11 (s1), 64-67
- https://doi.org/10.1046/j.1525-1438.2001.11(suppl.1)sup1064.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- High-Dose Chemotherapy and Autologous Stem-Cell Transplantation for Ovarian Cancer: An Autologous Blood and Marrow Transplant Registry ReportAnnals of Internal Medicine, 2000
- Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year ResultsJNCI Journal of the National Cancer Institute, 2000
- High dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) in ovarian cancerInternational Journal of Gynecologic Cancer, 2000
- Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer.Journal of Clinical Oncology, 1998
- How many more nails to seal the coffin of dose intensity?Annals of Oncology, 1997
- Tandem high-dose chemotherapy with ifosfamide, carboplatin, and teniposide with autologous bone marrow transplantation for the treatment of poor prognosis common epithelial ovarian carcinomaCancer, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Salvage Therapy for Recurrent and Refractory Ovarian Cancer with High-Dose Chemotherapy and Autologous Bone Marrow Support: A Gynecologic Oncology Group Pilot StudyGynecologic Oncology, 1994
- Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer.Journal of Clinical Oncology, 1992
- High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancerGynecologic Oncology, 1990